Flixonase Allergy & Hayfever 24 Hour is indicated for the prophylaxis and treatment of allergic rhinitis including hay fever and that caused by other airborne allergens such as house dust mite, mould spores and animal dander.

During treatment Flixonase Allergy & Hayfever 24 Hour provides symptomatic relief of sneezing, itchy and runny nose, congestion including associated sinus discomfort and pressure around the nose and eyes. Flixonase Allergy & Hayfever 24 Hour also provides relief of ocular symptoms associated with allergic rhinitis.


Flixonase Allergy & Hayfever 24 Hour is for administration by the intranasal route only.

Adults 18 years and over: For the prophylaxis and treatment of allergic rhinitis:

The recommended dose is two sprays into each nostril once a day, preferably in the morning. Once control is achieved the dose should be titrated down to one spray in each nostril once a day (100 micrograms per day).

In some cases two sprays into each nostril twice daily may be required for short periods to achieve control of symptoms, after which the dose should be titrated down.

The maximum daily dose should not exceed four sprays into each nostril

Onset of action in the treatment of allergic rhinitis has been observed in some patients as early as 2-4 hours after use, with most users achieving symptomatic relief within 12 hours of treatment.

Prophylaxis of allergic rhinitis requires treatment before contact with allergen.

For full therapeutic benefit regular usage is recommended.

Maximum benefit may require 3-4 days of continuous treatment in some people (Pharmacodynamic Properties).

Adolescents 12-17 years: Use only on medical advice.
Do not use in children under 12 years of age.


The normal adult dosage is applicable.


FLIXONASE Allergy & Hayfever 24 Hour is contra -indicated in patients with a hypersensitivity to fluticasone propionate or any other of the ingredients.

If improvement is not seen within 7 days of continuous use treatment should be stopped and the advice of a doctor sought.

If after 7 days of continuous use, symptoms have improved but are not adequately controlled then the advice of a pharmacist or doctor should be sought.

The nasal spray should not be used for more than 6 months continuously without consulting a doctor.

Local infection: Infections of the nasal airways should be appropriately treated but do not constitute a specific contraindication to treatment with intranasal fluticasone propionate

Care must be taken when withdrawing patients from systemic steroid treatment, and commencing therapy with intranasal fluticasone propionate, particularly if there is any reason to suspect that their adrenal function is impaired.

Systemic physiological and behavioural effects of nasal corticosteroids may occur, particularly at high doses prescribed for prolonged periods and in children. These effects are much less likely to occur than with oral corticosteroids and may vary in individual patients and between different corticosteroid preparations

  • Availability: 10 In Stock